Oncogenicity of viral hepatitis B and C in the initiation of hepatic cancer stem cells
Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape
Stereotactic ablative radiotherapy for hepatocellular carcinoma
A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy
Hepatocellular carcinoma in non-alcoholic fatty liver disease with and without cirrhosis
Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis
Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection
Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application
HCC incidence and recurrence after DAAs: new insights
Liver cancer screening in China: practices and its extended questions
Transarterial chemoembolization combined with radiofrequency ablation in the treatment of hepatocellular carcinomas larger than 5 cm
Molecular diagnosis and therapy of hepatocellular carcinoma: achievements and challenges
Liver carcinogenesis: diagnostic and clinical aspects of preneoplastic nodules
Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment
Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis
Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward
Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis
Contrast-enhanced ultrasound with sulphur-hexafluoride in diagnosis of early HCC in cirrhosis
Three primary malignancies in 17 years in a man with chronic hepatitis B
Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B
Third time re-irradiation of liver metastasis with robotic radiosurgery: a case series
Advances in early diagnosis of hepatocellular carcinoma
Hepatocellular carcinoma occurred in a Hepatitis B carrier clinic cohort during a mean follow up of 10 years
Hepatocellular carcinoma: a new hope?
Advances in surface markers of liver cancer stem cell
Management of concomitant hepatocellular carcinoma and chronic hepatitis C: a review
The secondary prevention of hepatitis B virus-associated hepatocellular carcinoma
The role of APOBEC3B in the development of hepatocellular carcinoma should be investigated with the consideration of hepatitis B virus evolution
No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis
Immune checkpoint blockade therapies for HCC: current status and future implications
Comment on “APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression”
The use of cell free DNA in the diagnosis of HCC
Hepatocellular carcinoma in HCV - liver cirrhosis before and after successful DAA treatment
Tumor growth rates and recurrence-free survival in chronic viral hepatitis patients with hepatocellular carcinoma
Updates in immunotherapy for hepatocellular carcinoma
Ten-year survival and recurrence of hepatocellular cancer
CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement
Hepatocellular carcinoma in alcoholic liver disease: mechanistic considerations and clinical facts
An update on the histological subtypes of hepatocellular carcinoma
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Epidemiology of hepatocellular carcinoma in nonalcoholic fatty liver disease
Technical update on transcatheter arterial chemoembolization